HALOPERIDOL AND REDUCED-HALOPERIDOL CONCENTRATIONS IN PLASMA FROM CHRONIC-SCHIZOPHRENIC PATIENTS

被引：3
|
作者：
AYMARD, N
LEYRIS, A
TOFFIS, V
VIALA, A
EPINETTE, C
DELTEIL, P
机构：
[1] UNIV PARIS 05,PHARMACOL LAB,F-75270 PARIS 06,FRANCE
[2] CHS ST ANNE,UNITE PHARMACOL,F-75014 PARIS,FRANCE
[3] CHS ST ANNE,SERV SANTE MENTALE,UNITE GEORGES CABANIS,F-75014 PARIS,FRANCE
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1990年 / 183卷 / 06期
关键词：
D O I：
10.1016/0014-2999(90)93854-J
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：2301 / 2302
页数：2
相关论文
共 50 条
  • [21] REVERSIBLE METABOLISM OF HALOPERIDOL AND REDUCED HALOPERIDOL IN CHINESE SCHIZOPHRENIC-PATIENTS
    JANN, MW
    LAM, YWF
    CHANG, WH
    PSYCHOPHARMACOLOGY, 1990, 101 (01) : 107 - 111
  • [22] DETERMINATION OF HALOPERIDOL AND REDUCED HALOPERIDOL IN THE PLASMA AND BLOOD OF PATIENTS ON DEPOT HALOPERIDOL
    EYLES, DW
    WHITEFORD, HA
    STEDMAN, TJ
    POND, SM
    PSYCHOPHARMACOLOGY, 1992, 106 (02) : 268 - 274
  • [23] A CLINICAL-TRIAL COMPARING INTRAMUSCULAR HALOPERIDOL DECANOATE AND ORAL HALOPERIDOL IN CHRONIC-SCHIZOPHRENIC PATIENTS - EFFICACY, SAFETY, AND DOSAGE EQUIVALENCE
    NAIR, NPV
    SURANYICADOTTE, B
    SCHWARTZ, G
    THAVUNDAYIL, JX
    ACHIM, A
    LIZONDO, E
    NAYAK, R
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1986, 6 (01) : S30 - S37
  • [24] Effects of the CYP2D6 genotype on the steady-state plasma concentrations of haloperidol and reduced haloperidol in Japanese schizophrenic patients
    Suzuki, A
    Otani, K
    Mihara, K
    Yasui, N
    Kaneko, S
    Inoue, Y
    Hayashi, K
    PHARMACOGENETICS, 1997, 7 (05): : 415 - 418
  • [25] FORMATION OF REDUCED HALOPERIDOL AFTER INTRAMUSCULAR HALOPERIDOL ADMINISTRATION IN SCHIZOPHRENIC-PATIENTS
    JANN, MW
    HUANG, HF
    LIN, SK
    JUANG, DJ
    LAM, YWF
    CHANG, WH
    DRUG INVESTIGATION, 1994, 7 (01): : 18 - 25
  • [26] DOSE-DEPENDENT REDUCED HALOPERIDOL HALOPERIDOL RATIOS IN SCHIZOPHRENIC-PATIENTS
    CHANG, WH
    HWU, HG
    LANE, HY
    LIN, SK
    CHEN, TY
    CHEN, H
    WEI, HL
    LIN, WL
    LIN, HN
    PSYCHIATRY RESEARCH, 1991, 38 (03) : 215 - 225
  • [27] STEADY-STATE PHARMACOKINETICS OF HALOPERIDOL AND REDUCED HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS - ANALYSIS OF FACTORS DETERMINING THEIR CONCENTRATIONS IN HAIR
    UEMATSU, T
    MATSUNO, H
    SATO, H
    HIRAYAMA, H
    HASEGAWA, K
    NAKASHIMA, M
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (10) : 1008 - 1011
  • [28] PROLONGED HALOPERIDOL AND REDUCED HALOPERIDOL PLASMA-CONCENTRATIONS AFTER DECANOATE WITHDRAWAL
    CHANG, WH
    LIN, SK
    JUANG, DJ
    CHEN, LC
    YANG, CH
    HU, WH
    CHIEN, CP
    LAM, YWF
    JANN, MW
    SCHIZOPHRENIA RESEARCH, 1993, 9 (01) : 35 - 40
  • [29] LOW PLASMA REDUCED HALOPERIDOL HALOPERIDOL RATIOS IN CHINESE PATIENTS
    CHANG, WH
    CHEN, TY
    LEE, CF
    HU, WH
    YEH, EK
    BIOLOGICAL PSYCHIATRY, 1987, 22 (11) : 1406 - 1408
  • [30] PHARMACOKINETICS OF HALOPERIDOL AND REDUCED HALOPERIDOL IN CHINESE SCHIZOPHRENIC-PATIENTS AFTER INTRAVENOUS AND ORAL-ADMINISTRATION OF HALOPERIDOL
    CHANG, WH
    LAM, YWF
    JANN, MW
    CHEN, H
    PSYCHOPHARMACOLOGY, 1992, 106 (04) : 517 - 522
12345